Prevalence of metabolic syndrome among obese diabetic subjects

Background: Metabolic syndrome (MS) is a cluster of metabolic risk factors including obesity, glucose intolerance, insulin resistance, dyslipidemia and hypertension. MS in obese and type 2 diabetic (T2DM) subjects increases the risk of cardiovascular diseases (CVD). The objective of the present stud...

Full description

Bibliographic Details
Main Authors: Mehwish Zeeshan, Muhammad Imran, Humaira Jabeen, Sumreen Begum, Nazia Ahmed, Rashida Qasim
Format: Article
Language:English
Published: Advance Educational Institute & Research Centre 2015-12-01
Series:International Journal of Endorsing Health Science Research
Subjects:
Online Access:http://aeirc-edu.com/ojs14/index.php/IJEHSR/article/view/112/367
_version_ 1818823987379044352
author Mehwish Zeeshan
Muhammad Imran
Humaira Jabeen
Sumreen Begum
Nazia Ahmed
Rashida Qasim
author_facet Mehwish Zeeshan
Muhammad Imran
Humaira Jabeen
Sumreen Begum
Nazia Ahmed
Rashida Qasim
author_sort Mehwish Zeeshan
collection DOAJ
description Background: Metabolic syndrome (MS) is a cluster of metabolic risk factors including obesity, glucose intolerance, insulin resistance, dyslipidemia and hypertension. MS in obese and type 2 diabetic (T2DM) subjects increases the risk of cardiovascular diseases (CVD). The objective of the present study is to estimate the prevalence of MS in obese T2DM subjects by using International Diabetes Federation (IDF) and National Cholesterol Education Program-Adult Treatment Panel III (NCEP-ATP III) definitions. Methods: Obese T2DM (n=70) and normal healthy subjects (n=30) of both genders were selected from hospitals and diabetic centers of various localities of Karachi, Pakistan. The frequency of MS was estimated by utilizing criteria of the proposed definitions of IDF and NCEP-ATP III. Results: The prevalence of MS using IDF definition in obeseT2DM subjects was 85.7%. It is significantly higher (p≤0.05) in females (45.70%) as compared to males (30.0%). While, using NCEP-ATP III definition the overall prevalence of MS in obese T2DM subjects was 75.7%, the prevalence is significantly higher (p≤0.05) in females (47.1%) than males (38.6%). The development of MS was highly observed between 31 – 40 years of age under criteria of both definitions. Conclusion It is concluded that, the overall prevalence of MS is increasing significantly in obese T2DM subjects by using IDF and NCEP – ATP III definitions. However, IDF is more stringent for defining MS. Therefore, it is needed to initiate the preventive measures of a healthy lifestyle and emphasis should be given to reduce weight, increase physical activity, and increase intake of healthy low-glycemic-index foods.
first_indexed 2024-12-18T23:48:42Z
format Article
id doaj.art-fc09b393bb7b4970928c1e4f7fae6b32
institution Directory Open Access Journal
issn 2307-3748
2310-3841
language English
last_indexed 2024-12-18T23:48:42Z
publishDate 2015-12-01
publisher Advance Educational Institute & Research Centre
record_format Article
series International Journal of Endorsing Health Science Research
spelling doaj.art-fc09b393bb7b4970928c1e4f7fae6b322022-12-21T20:47:08ZengAdvance Educational Institute & Research CentreInternational Journal of Endorsing Health Science Research2307-37482310-38412015-12-01342328https://doi.org/10.29052/IJEHSR.v3.i4.2015.23-28Prevalence of metabolic syndrome among obese diabetic subjectsMehwish Zeeshan0Muhammad Imran1Humaira Jabeen2Sumreen Begum3Nazia Ahmed4Rashida Qasim5College of Allied Health Sciences, Ziauddin University, KarachiCollege of Allied Health Sciences, Ziauddin University, KarachiCollege of Allied Health Sciences, Ziauddin University, KarachiCollege of Allied Health Sciences, Ziauddin University, KarachiCollege of Allied Health Sciences, Ziauddin University, KarachiCollege of Allied Health Sciences, Ziauddin University, KarachiBackground: Metabolic syndrome (MS) is a cluster of metabolic risk factors including obesity, glucose intolerance, insulin resistance, dyslipidemia and hypertension. MS in obese and type 2 diabetic (T2DM) subjects increases the risk of cardiovascular diseases (CVD). The objective of the present study is to estimate the prevalence of MS in obese T2DM subjects by using International Diabetes Federation (IDF) and National Cholesterol Education Program-Adult Treatment Panel III (NCEP-ATP III) definitions. Methods: Obese T2DM (n=70) and normal healthy subjects (n=30) of both genders were selected from hospitals and diabetic centers of various localities of Karachi, Pakistan. The frequency of MS was estimated by utilizing criteria of the proposed definitions of IDF and NCEP-ATP III. Results: The prevalence of MS using IDF definition in obeseT2DM subjects was 85.7%. It is significantly higher (p≤0.05) in females (45.70%) as compared to males (30.0%). While, using NCEP-ATP III definition the overall prevalence of MS in obese T2DM subjects was 75.7%, the prevalence is significantly higher (p≤0.05) in females (47.1%) than males (38.6%). The development of MS was highly observed between 31 – 40 years of age under criteria of both definitions. Conclusion It is concluded that, the overall prevalence of MS is increasing significantly in obese T2DM subjects by using IDF and NCEP – ATP III definitions. However, IDF is more stringent for defining MS. Therefore, it is needed to initiate the preventive measures of a healthy lifestyle and emphasis should be given to reduce weight, increase physical activity, and increase intake of healthy low-glycemic-index foods.http://aeirc-edu.com/ojs14/index.php/IJEHSR/article/view/112/367metabolic syndromediabetes mellitusinsulin resistance obesityatherosclerotic cardiovascular diseaseidfncep-atp iii
spellingShingle Mehwish Zeeshan
Muhammad Imran
Humaira Jabeen
Sumreen Begum
Nazia Ahmed
Rashida Qasim
Prevalence of metabolic syndrome among obese diabetic subjects
International Journal of Endorsing Health Science Research
metabolic syndrome
diabetes mellitus
insulin resistance obesity
atherosclerotic cardiovascular disease
idf
ncep-atp iii
title Prevalence of metabolic syndrome among obese diabetic subjects
title_full Prevalence of metabolic syndrome among obese diabetic subjects
title_fullStr Prevalence of metabolic syndrome among obese diabetic subjects
title_full_unstemmed Prevalence of metabolic syndrome among obese diabetic subjects
title_short Prevalence of metabolic syndrome among obese diabetic subjects
title_sort prevalence of metabolic syndrome among obese diabetic subjects
topic metabolic syndrome
diabetes mellitus
insulin resistance obesity
atherosclerotic cardiovascular disease
idf
ncep-atp iii
url http://aeirc-edu.com/ojs14/index.php/IJEHSR/article/view/112/367
work_keys_str_mv AT mehwishzeeshan prevalenceofmetabolicsyndromeamongobesediabeticsubjects
AT muhammadimran prevalenceofmetabolicsyndromeamongobesediabeticsubjects
AT humairajabeen prevalenceofmetabolicsyndromeamongobesediabeticsubjects
AT sumreenbegum prevalenceofmetabolicsyndromeamongobesediabeticsubjects
AT naziaahmed prevalenceofmetabolicsyndromeamongobesediabeticsubjects
AT rashidaqasim prevalenceofmetabolicsyndromeamongobesediabeticsubjects